Adalimumab-Induced Isolated Peritoneal Tuberculosis
Abstract: The therapeutic approach to immune-mediated diseases including Crohn's disease has dramatically improved with the introduction of immunomodulators such as anti-tumor necrosis factor (TNF). However, its use is not complication-free, and since its introduction, a growing number of opportunistic infections is being reported in patients under treatment despite all preventive measures taken. Herein, we report a case of adalimumab-induced isolated peritoneal tuberculosis.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Adalimumab-Induced Isolated Peritoneal Tuberculosis ; day:04 ; month:04 ; year:2023
International journal of recent surgical and medical science ; (04.04.2023)
- Beteiligte Personen und Organisationen
-
Saad, Melissa Kyriakos
Ghandour, Fatme
Saikaly, Elias
- DOI
-
10.1055/s-0043-1761477
- URN
-
urn:nbn:de:101:1-2023051811124861640364
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saad, Melissa Kyriakos
- Ghandour, Fatme
- Saikaly, Elias
Ähnliche Objekte (12)
Abdominal tuberculosis mimicking peritoneal metastasis
Peritoneal Tuberculosis in Infants: Diagnostic Challenges
A rare case of peritoneal tuberculosis mimicking peritoneal carcinomatosis: the ongoing challenge
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Isolated Gastric Tuberculosis: A Case Report
Isolated Gallbladder Tuberculosis with Postoperative Biliary Fistula
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)
Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis
AVT02: An Adalimumab Biosimilar
Isolated anterior mediastinal tuberculosis in an immunocompetent patient
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Molecular typing of Mycobacterium tuberculosis complex isolated from pulmonary tuberculosis patients in central Ethiopia
Abdominal tuberculosis mimicking peritoneal metastasis
Peritoneal Tuberculosis in Infants: Diagnostic Challenges
A rare case of peritoneal tuberculosis mimicking peritoneal carcinomatosis: the ongoing challenge
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Isolated Gastric Tuberculosis: A Case Report
Isolated Gallbladder Tuberculosis with Postoperative Biliary Fistula
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)
Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis
AVT02: An Adalimumab Biosimilar
Isolated anterior mediastinal tuberculosis in an immunocompetent patient
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Molecular typing of Mycobacterium tuberculosis complex isolated from pulmonary tuberculosis patients in central Ethiopia
Abdominal tuberculosis mimicking peritoneal metastasis
Peritoneal Tuberculosis in Infants: Diagnostic Challenges
A rare case of peritoneal tuberculosis mimicking peritoneal carcinomatosis: the ongoing challenge
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Isolated Gastric Tuberculosis: A Case Report
Isolated Gallbladder Tuberculosis with Postoperative Biliary Fistula
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)
Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis
AVT02: An Adalimumab Biosimilar
Isolated anterior mediastinal tuberculosis in an immunocompetent patient
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab